Cargando…
Bioactive cationic peptides as potential agents for breast cancer treatment
Breast cancer continues to affect millions of women worldwide, and the number of new cases dramatically increases every year. The physiological causes behind the disease are still not fully understood. One in every 100 cases can occur in men, and although the frequency is lower than among women, men...
Autores principales: | Manrique-Moreno, Marcela, Santa-González, Gloria A., Gallego, Vanessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655503/ https://www.ncbi.nlm.nih.gov/pubmed/34874400 http://dx.doi.org/10.1042/BSR20211218C |
Ejemplares similares
-
Cell cycle progression data on human skin cancer cells with anticancer synthetic peptide LTX-315 treatment
por: Santa-González, Gloria A., et al.
Publicado: (2020) -
Thermostability-based binding assays reveal complex interplay of cation, substrate and lipid binding in the bacterial DASS transporter, VcINDY
por: Sampson, Connor D. D., et al.
Publicado: (2021) -
Antimicrobial peptide CGA-N12 decreases the Candida tropicalis mitochondrial membrane potential via mitochondrial permeability transition pore
por: Li, Ruifang, et al.
Publicado: (2020) -
Synthetic Peptide ΔM4-Induced Cell Death Associated with Cytoplasmic Membrane Disruption, Mitochondrial Dysfunction and Cell Cycle Arrest in Human Melanoma Cells
por: Santa-González, Gloria A., et al.
Publicado: (2020) -
ΔM4: Membrane-Active Peptide with Antitumoral Potential against Human Skin Cancer Cells
por: Fandiño-Devia, Estefanía, et al.
Publicado: (2023)